Pulmonary involvement in juvenile dermatomyositis: a two-year longitudinal study

Area of Science:

• Pediatric Rheumatology
• Pulmonology
• Clinical Immunology

Background:

• Juvenile dermatomyositis (JDM) is an autoimmune disease primarily affecting children.
• Pulmonary involvement in JDM can be asymptomatic and difficult to detect.
• Early identification of lung disease in JDM is essential for timely intervention.

Purpose of the Study:

• To determine the prevalence and characteristics of subclinical lung disease in JDM patients.
• To assess changes in pulmonary function over time in JDM.
• To identify factors associated with pulmonary impairment in JDM.

Main Methods:

• Pulmonary function tests (PFTs) including FEV1, FVC, DLCO, and alveolar volume were performed at baseline, 12, and 24 months in 12 JDM patients.
• Disease activity, duration, serum lactate dehydrogenase (LDH), and antinuclear antibody (ANA) titers were assessed.
• Longitudinal evaluation of pulmonary function and its correlation with clinical and laboratory parameters.

Main Results:

• Pulmonary impairment was observed in 5 patients at baseline and 4 patients at 12 and 24 months, indicating a stable prevalence.
• A restrictive pattern and impaired diffusion (reduced FVC and DLCO) were the most common findings.
• Lower FVC correlated with higher LDH and active disease, while lower DLCO was associated with positive ANA titers.

Conclusions:

• Approximately half of the JDM patients in this series exhibited asymptomatic pulmonary involvement.
• Pulmonary function tests are valuable for detecting unpredictable lung disease in JDM.
• Regular lung function monitoring from disease onset is recommended for JDM patients.